Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81851758 | 8185175 | 8 | F | 20101211 | 20160629 | 20111018 | 20160705 | EXP | US-ASTRAZENECA-2010SE59781 | ASTRAZENECA | 26981.00 | DY | F | Y | 72.60000 | KG | 20160705 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81851758 | 8185175 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS BID | U | U | 3000296D00,3000725C00 | 21929 | BID | ||||||
| 81851758 | 8185175 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG,UNKNOWN UNKNOWN | U | U | 21929 | ||||||||
| 81851758 | 8185175 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | QD | |||||
| 81851758 | 8185175 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | QD | |||||
| 81851758 | 8185175 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | BID | |||||
| 81851758 | 8185175 | 6 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | CAPSULE | BID | |||||
| 81851758 | 8185175 | 7 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | GENERIC, ESOMEPRAZOLE | U | U | 0 | ||||||||
| 81851758 | 8185175 | 8 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | GENERIC, ESOMEPRAZOLE | U | U | 0 | ||||||||
| 81851758 | 8185175 | 9 | SS | NEXIUM 24HR | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | CAPSULE | |||||||||
| 81851758 | 8185175 | 10 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 81851758 | 8185175 | 11 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 81851758 | 8185175 | 12 | C | ALVESCO | CICLESONIDE | 1 | 0 | ||||||||||||
| 81851758 | 8185175 | 13 | C | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | 1 | Respiratory (inhalation) | PRN | 0 | ||||||||||
| 81851758 | 8185175 | 14 | C | HRT PATCH | 2 | Topical | 0 | TRANSDERMAL PATCH | |||||||||||
| 81851758 | 8185175 | 15 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 81851758 | 8185175 | 16 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 81851758 | 8185175 | 1 | Chronic obstructive pulmonary disease |
| 81851758 | 8185175 | 2 | Chronic obstructive pulmonary disease |
| 81851758 | 8185175 | 3 | Gastrooesophageal reflux disease |
| 81851758 | 8185175 | 4 | Gastrooesophageal reflux disease |
| 81851758 | 8185175 | 5 | Gastrooesophageal reflux disease |
| 81851758 | 8185175 | 6 | Gastrooesophageal reflux disease |
| 81851758 | 8185175 | 7 | Gastrooesophageal reflux disease |
| 81851758 | 8185175 | 8 | Gastrooesophageal reflux disease |
| 81851758 | 8185175 | 10 | Chronic obstructive pulmonary disease |
| 81851758 | 8185175 | 11 | Chronic obstructive pulmonary disease |
| 81851758 | 8185175 | 13 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 81851758 | 8185175 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 81851758 | 8185175 | Cataract | |
| 81851758 | 8185175 | Constipation | |
| 81851758 | 8185175 | Drug dose omission | |
| 81851758 | 8185175 | Drug ineffective | |
| 81851758 | 8185175 | Dyspnoea | |
| 81851758 | 8185175 | Dyspnoea exertional | |
| 81851758 | 8185175 | Intentional product misuse | |
| 81851758 | 8185175 | Intervertebral disc disorder | |
| 81851758 | 8185175 | Malaise | |
| 81851758 | 8185175 | Overweight | |
| 81851758 | 8185175 | Snake bite | |
| 81851758 | 8185175 | Spinal cord disorder | |
| 81851758 | 8185175 | Spinal osteoarthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 81851758 | 8185175 | 1 | 2008 | 0 | ||
| 81851758 | 8185175 | 2 | 201208 | 0 | ||
| 81851758 | 8185175 | 10 | 201010 | 0 | ||
| 81851758 | 8185175 | 12 | 2008 | 0 |